NICHOLAS ALEXANDER: Open Payments
NPI 1841044526 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 15 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $197 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: OTEZLA, TRELEGY ELLIPTA, REXULTI, XIFAXAN, Auvelity, JARDIANCE, UBRELVY, EVENITY.
Industry payments across IN — which companies pay providers there.
